The news, progress, whereabouts, and ephemera from the Computational Chemical Biology group at the EMBL-EBI.
Despite the description as an antineoplastic the compound does appear to be one of the JAK inhibitors claimed in WO2007084557, which would indeed suggest it to be VX-509
So, it looks like it is VX-509. I mailed Jeremy over his source, and he also said it was patents. I'll write up a short follow on post with a walk through of how to find this sort of stuff.Jeremy and Peter, your prize is some cake and tea at Chemblton (the ancient name of the village of Hinxton apparently) so when you are in the area, come and claim your prize.
Post a Comment